According to Edward Deming, uncontrolled variation is the enemy of quality and quite a bit of uncontrolled variation exists in the medical device industry today. There are several ways to approach strategic contracting and partnerships in the healthcare supply chain arena. One option is using dis-intermediation, or a rep-less model, for medical device purchases. In this webinar, we will review the current industry model for medical device sales and the opportunity for innovation in this space. We’ll review a strategic approach to the seven objections, from physicians and the c-suite, and then move into preparing a business case for this model. Results from a pilot project will be shared along with the critical success factors for implementing a rep-less model.
|Activity Number||Credit Amount||Accreditation Period|
|AHRMM||1 Hour||from December 06, 2018|